Dark

FLGT
Fulgent Genetics, Inc. Common Stock
stock NASDAQ

At Close

Aug 7, 2026 3:59:47 PM EDT

19.15USD+3.234%(+0.60)228,363

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-18.55)0

After-hours

Aug 7, 2026 4:00:30 PM EDT

19.14USD-0.052%(-0.01)44,416

OverviewOptionsHistoricalExchangesShortsNews

Jan 25, 2022

07:35AM EST Oppenheimer Maintains Outperform on Fulgent Genetics, Lowers Price Target to $125 Benzinga

Dec 22, 2021

01:54PM EST Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave Benzinga

Dec 20, 2021

09:47AM EST 5 Value Stocks In The Healthcare Sector Benzinga

Dec 6, 2021

08:03AM EST Helio Health Announces The Commercial Launch Of HelioLiver Benzinga

Dec 2, 2021

07:51AM EST The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance Benzinga

Dec 1, 2021

04:42PM EST Fulgent Genetics Reports Confirmation Of Ability To Detect Omicron Variant With PCR Tests For COVID-19 Benzinga

Nov 22, 2021

09:45AM EST A Look Into Healthcare Sector Value Stocks Benzinga

Nov 16, 2021

01:04PM EST Fulgent Genetics Option Alert: Jan 21 $125 Calls Sweep (32) near the Ask: 244 @ $2.3 vs 65 OI; Ref=$96.26 Benzinga

Nov 10, 2021

07:06AM EST Fulgent Genetics Q3 Revenues More Than Double; Raises FY21 Outlook Benzinga

Nov 9, 2021

05:04PM EST Fulgent Genetics: Q3 Earnings Insights Benzinga

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

08:00AM EST Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences Business Wire

Nov 8, 2021

08:29AM EST The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More Benzinga

08:06AM EST Helio Health, Fulgent Genetics Announce Late-Breaking Performance Data Of HelioLiver For Early Liver Cancer Detection Benzinga

08:03AM EST Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance PR Newswire

Nov 2, 2021

10:23AM EDT Helio Health And Fulgent Genetics To Present At The Liver Meeting 2021 Nov. 12-15 Benzinga

Nov 1, 2021

04:06PM EDT Helio Health and Fulgent Genetics to Present New Data on HelioLiver in PR Newswire

Oct 27, 2021

08:13AM EDT Fulgent Genetics Launches At-Home Neutralizing Antibody Test For COVID-19 Benzinga

Oct 25, 2021

08:00AM EDT Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021 Business Wire

Sep 23, 2021

04:06PM EDT Fulgent Genetics To Partner With Houston Health Department And Houston-Area Public Schools On Back-to-School COVID-19 Testing Program Benzinga

Sep 14, 2021

11:19AM EDT Fulgent Genetics's Return on Invested Capital Overview Benzinga

Aug 10, 2021

09:58AM EDT Credit Suisse Maintains Underperform on Fulgent Genetics, Raises Price Target to $65 Benzinga

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

06:37AM EDT Fulgent Genetics Stock Falls As Q2 Earnings Miss Street Estimates; Lowers FY21 Sales Outlook Benzinga

Aug 9, 2021

04:45PM EDT Recap: Fulgent Genetics Q2 Earnings Benzinga

04:41PM EDT Fulgent Genetics Q2 EPS $2.55 Misses $2.81 Estimate, Sales $153.62M Miss $197.34M Estimate Benzinga

04:04PM EDT Fulgent Genetics And Helio Health Announce Partnership To Commercialize Early Cancer Detection Tests; Financial Details Not Disclosed Benzinga

04:03PM EDT Fulgent Genetics Reports Purchase Of CSI Labs, No Terms Disclosed Benzinga

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

04:11AM EDT Earnings Scheduled For August 9, 2021 Benzinga

Aug 8, 2021

10:11AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Jun 28, 2021

10:27AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

Jun 4, 2021

01:40PM EDT AMC Goes Parabolic: Looking For The Next Short Squeeze Candidate. Benzinga

May 17, 2021

09:45AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

May 10, 2021

08:55AM EDT Fulgent Genetics Announces ~$19M Investment In Chinese Joint Venture, FF Gene Biotech Benzinga

08:00AM EDT Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech Business Wire

May 6, 2021

04:57PM EDT UPDATE: Fulgent Genetics Raises FY21 Sales Guidance From ~$800M To ~$830M vs $789.4M Estimate, Reaffirms Adj. EPS Guidance $12.50 vs $12.27 Est. Benzinga

04:56PM EDT Fulgent Genetics Q1 Adj. EPS $6.59 Beats $5.86 Estimate, Sales $359.40M Beat $321.51M Estimate; Raises Guidance Benzinga

04:07PM EDT Fulgent Genetics Reports Record First Quarter Financial Results Business Wire

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 16, 2021

08:00AM EDT Fulgent Genetics to Announce First Quarter 2021 Financial Results GlobeNewswire Inc

Mar 16, 2021

08:17AM EDT The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga

Mar 15, 2021

04:07PM EDT Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus Benzinga

04:05PM EDT Fulgent Genetics Awarded Contract from CDC to Study Variants of GlobeNewswire Inc

Mar 5, 2021

09:45AM EST Shares of Fulgent Genetics Inc. (FLGT) are soaring over 15% Friday morning. The stock, which has been trading in the range of $6.70 - $189.89 for the past one year, is currently trading at $98.40, up $12.87 or 15.05%, with trading volume of over 1.04 million versus an average volume of 2.12 million shares. RTTNews

09:13AM EST Piper Sandler Maintains Overweight on Fulgent Genetics, Raises Price Target to $140 Benzinga

08:00AM EST Fulgent Genetics to Participate in the Oppenheimer 31st Annual GlobeNewswire Inc

Mar 4, 2021

04:58PM EST Recap: Fulgent Genetics Q4 Earnings Benzinga

04:16PM EST Fulgent Genetics Sees FY21 EPS ~$12.50 Vs. $11.55 Est., Sales ~$800M Vs. $600.24M Est. Benzinga

04:15PM EST Fulgent Genetics Q4 EPS $6.20 Beats $4.05 Estimate, Sales $295.00M Beat $199.44M Estimate Benzinga

04:05PM EST Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 GlobeNewswire Inc

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

04:07AM EST Earnings Scheduled For March 4, 2021 Benzinga

Feb 27, 2021

09:04PM EST The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings Benzinga

Feb 18, 2021

08:00AM EST Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 GlobeNewswire Inc

Feb 10, 2021

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Feb 2, 2021

08:05AM EST The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment Benzinga

Feb 1, 2021

11:49AM EST Oppenheimer Maintains Outperform on Fulgent Genetics, Raises Price Target to $130 Benzinga

Jan 29, 2021

07:45AM EST The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO Benzinga

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 27, 2021

10:07AM EST Stocks That Hit 52-Week Highs On Wednesday Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 8, 2021

10:04AM EST Benzinga's Top Upgrades, Downgrades For January 8, 2021 Benzinga

08:07AM EST Credit Suisse Downgrades Fulgent Genetics to Underperform Benzinga

Jan 6, 2021

08:00AM EST Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT GlobeNewswire Inc

07:31AM EST The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga

Jan 5, 2021

08:39AM EST The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data Benzinga

Dec 29, 2020

08:27AM EST Fulgent Genetics, Inc. (FLGT) announced Tuesday that it has extended its partnership with the New York City Department of Education (NYC DOE) and NYC Health + Hospitals for COVID-19 testing through the remainder of the 2021 school year. RTTNews

08:16AM EST Fulgent Extends Partnership With NYC DOE For COVID-19 Testing Through Remainder Of 2021 School Year RTTNews

08:01AM EST Fulgent Genetics Extends Partnership Sith New York City Test And Trace For COVID-19 Testing, Awarded Contract For 2021 School Year Benzinga

08:00AM EST Fulgent Genetics Extends Partnership with New York City Test and GlobeNewswire Inc

Dec 22, 2020

05:11PM EST Ming Hsieh Reports In 13D Filing A 32.5% Stake In Flugent Genetics Benzinga

Dec 17, 2020

04:02PM EST PRA Health Reports Collaboration With PWNHealth, Fulgent Genetics To Provide At-Home COVID-19 Test Capabilities Benzinga

04:02PM EST PRA Health Sciences collaborates with PWNHealth and Fulgent GlobeNewswire Inc

Dec 11, 2020

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Nov 24, 2020

09:51AM EST Benzinga's Top Upgrades, Downgrades For November 24, 2020 Benzinga

08:00AM EST Fulgent Genetics to Participate in the Piper Sandler 32nd Annual GlobeNewswire Inc

05:53AM EST BTIG Downgrades Fulgent Genetics to Neutral Benzinga

Nov 23, 2020

10:02AM EST Fulgent Genetics shares were trading higher after the company raised its FY20 sales guidance above analyst estimates. Benzinga

08:06AM EST Fulgent Genetics Raises FY20 Sales Guidance From ~$235M To ~$300M Vs. $237.38M Est. Benzinga

08:00AM EST Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. GlobeNewswire Inc

Nov 18, 2020

08:38AM EST LANES, Fulgent Genetics And LA County Department Of Health Services Announce Partnership To Support Data Exchange Of COVID-19 Test Results To Local Healthcare Providers Benzinga

08:30AM EST LANES, Fulgent Genetics and LA County Department of Health Services Collaborate PR Newswire

Nov 17, 2020

12:39PM EST Tiffany McGhee On CNBC: I Bought Fulgent Genetics, United Microelectronics Benzinga

Nov 13, 2020

08:41AM EST Yahoo Finance Trending Stocks For Friday, Nov. 13, 2020: LI, NIO, DKNG, FSLY, DIS, CSCO, SOLO, CBAT, FSR, WKHS, HOFV, BIGC, KCAC, FTCH, AYRO, KNDI, SAVA, UROV, SPI, VIPS, NIU, BOXL, NETE, NAVB, U, ZOM, VFF, FLGT, BYDDF Benzinga

Nov 10, 2020

04:05PM EST Fulgent Genetics to Participate in the Credit Suisse 29th Annual GlobeNewswire Inc

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 9, 2020

04:38PM EST Fulgent Genetics Q3 EPS $2.08 Up From $0.14 YoY, Sales $101.70M Up From $10.35M YoY Benzinga

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Oct 26, 2020

08:01AM EDT Fulgent Genetics to Announce Third Quarter 2020 Financial Results GlobeNewswire Inc

Sep 30, 2020

08:13AM EDT Fulgent Genetics Announces Partnership with Ohio Department of Rehabilitation and Correction for COVID-19 Testing Benzinga

08:00AM EDT Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that the Ohio Department of Rehabilitation and Correction (ODRC) has selected Fulgent Genetics for their COVID-19 testing needs. GlobeNewswire Inc

Sep 25, 2020

08:25AM EDT Fulgent Genetics Entered Into Equity Distribution Agreement With Piper Sandler Relating To Shares Of Common Stock Offered By Prospectus Supplement Benzinga

08:22AM EDT Credit Suisse Maintains Neutral on Fulgent Genetics, Raises Price Target to $42 Benzinga

Sep 22, 2020

10:09AM EDT Shares of Fulgent Genetics, Inc. (FLGT), a provider of genetic testing services, are rising more than 7 percent or $2.79 in Tuesday's morning trade at $40.38. RTTNews

Sep 21, 2020

06:42PM EDT Fulgent Genetics Set to Join S&P SmallCap 600 PR Newswire

05:16PM EDT S&P Dow Jones Indices Announces Fulgent Genetics To Join S&P SmallCap 600, Will Replace Garrett Motion Benzinga

Sep 18, 2020

09:01AM EDT Cramer Advises Viewers On Peloton, Vale And More Benzinga

Sep 15, 2020

01:53PM EDT Fulgent Genetics shares are trading higher after the company provided coronavirus testing solutions for the State of Utah. Benzinga

08:10AM EDT Fulgent Genetics To Provide Coronavirus Testing Solutions For State Of Utah Benzinga

08:01AM EDT Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with the State of Utah for COVID-19 testing. GlobeNewswire Inc

Sep 9, 2020

08:07AM EDT Fulgent Genetics And Miami-Dade County Partner On COVID-19 testing Benzinga

08:00AM EDT Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. GlobeNewswire Inc

Sep 4, 2020

08:00AM EDT Fulgent Genetics to Participate in the H.C. Wainwright 22nd Annual GlobeNewswire Inc

Sep 3, 2020

12:13PM EDT Mid-Day Market Update: Dow Tumbles Over 500 Points; Fulgent Genetics Shares Jump Benzinga

11:01AM EDT Shares of Fulgent Genetics Inc. (FLGT) are currently gaining nearly 20% on Thursday morning. The other day, the genetic testing services company said it would supply COVID-19 testing to hundreds of thousands of students in collaboration with New York City Health and Hospitals at nearly 1,600 locations. RTTNews

10:18AM EDT Mid-Morning Market Update: Markets Open Lower; Campbell Soup Beats Q4 Views Benzinga

06:05AM EDT Fulgent Genetics Reports Addition Of Influenza A, B To All Coronavirus Tests Benzinga

06:00AM EDT Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that beginning September 28th, all patients tested for COVID-19 by Fulgent Genetics will also receive results for Influenzas A and B. GlobeNewswire Inc

Sep 2, 2020

09:25PM EDT Fulgent Shares Up 10% On COVID-19 Testing Deal For New York Schools Benzinga

05:36PM EDT After Hours Market: PVH, Fulgent Genetics, Applied Genetic RTTNews

04:08PM EDT Fulgent Genetics, New York City Health And Hospitals Partner On Large-Scale Back-To-School COVID-19 Testing Benzinga

04:05PM EDT Fulgent Genetics, N GlobeNewswire Inc

Aug 27, 2020

10:28AM EDT Mid-Morning Market Update: Markets Mostly Higher; Dollar General Profit Beats Views Benzinga

Aug 20, 2020

09:51AM EDT Benzinga's Top Upgrades, Downgrades For August 20, 2020 Benzinga

06:28AM EDT Oppenheimer Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $75 Benzinga

Aug 17, 2020

07:00AM EDT CLIA-Certified Laboratory will Increase Testing CapacityRaising FY20 Revenue Guidance to $135 Million from $120 Million GlobeNewswire Inc

Aug 14, 2020

08:26AM EDT The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal Benzinga

Aug 13, 2020

08:18AM EDT The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller Benzinga

Aug 6, 2020

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Aug 5, 2020

10:17AM EDT Shares of technology company providing comprehensive testing solutions through its scalable technology platform Fulgent Genetics, Inc. (FLGT) are rising more than 20% Wednesday morning on upbeat second-quarter results. RTTNews

09:48AM EDT Morning Market Stats in 5 Minutes Benzinga

09:43AM EDT Flugent Genetics Shares Up 21%; Hearing Piper Raises Price Target From $31 To $68 Benzinga

Aug 4, 2020

04:35PM EDT Fulgent Genetics Q2 EPS $0.17 Up From $0.06 YoY, Sales $17.30M Beat $10.02M Estimate Benzinga

04:05PM EDT Fulgent Genetics Reports Record Second Quarter 2020 Financial Results GlobeNewswire Inc

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Jul 27, 2020

04:42PM EDT Fulgent Genetics On July 23, Entered Purchase Agreement For Property In California For Payment Of $15.4M Benzinga

09:40AM EDT Piper Sandler Maintains Overweight on Fulgent Genetics, Raises Price Target to $31 Benzinga

Jul 21, 2020

06:06AM EDT Fulgent Genetics Inc Files For Mixed Shelf Of Up To $300M Benzinga

Jul 14, 2020

08:01AM EDT Fulgent Genetics to Announce Second Quarter 2020 Financial Results GlobeNewswire Inc